Table 4.
Cytokine* | Kynurenine | Kynurenine/TRP | KYNA | QUIN | IDO1 | IDO2 | TDO2 | KAT II | KMO |
---|---|---|---|---|---|---|---|---|---|
IL6 (n = 70) | |||||||||
r | 0.325 | 0.428 | 0.304 | 0.230 | 0.347 | 0.366 | 0.279 | 0.054 | 0.224 |
p† | 0.006 | < 0.001 | 0.011 | 0.06 | 0.004 | 0.003 | 0.021 | 0.67 | 0.06 |
adj p‡ | 0.015 | 0.001 | 0.024 | 0.09 | 0.009 | 0.007 | 0.039 | 0.70 | 0.10 |
IL13 (n = 69) | |||||||||
r | 0.241 | 0.278 | 0.121 | 0.162 | 0.484 | 0.507 | 0.501 | 0.150 | 0.360 |
p† | 0.046 | 0.021 | 0.32 | 0.19 | < 0.001 | < 0.001 | < 0.001 | 0.22 | 0.002 |
adj p‡ | 0.08 | 0.039 | 0.38 | 0.23 | 0.001 | 0.001 | 0.001 | 0.27 | 0.007 |
IL33 (n = 56) | |||||||||
r | −0.067 | 0.413 | 0.119 | 0.166 | 0.415 | 0.467 | 0.540 | 0.381 | 0.341 |
p† | 0.63 | 0.002 | 0.38 | 0.22 | 0.002 | < 0.001 | < 0.001 | 0.004 | 0.010 |
adj p‡ | 0.68 | 0.005 | 0.44 | 0.27 | 0.005 | 0.002 | < 0.001 | 0.010 | 0.023 |
IFN-γ (n = 69) | |||||||||
r | 0.087 | 0.262 | 0.035 | 0.190 | 0.689 | 0.755 | 0.533 | 0.167 | 0.381 |
p† | 0.48 | 0.030 | 0.78 | 0.12 | < 0.001 | < 0.001 | < 0.001 | 0.18 | 0.001 |
adj p‡ | 0.53 | 0.05 | 0.79 | 0.17 | < 0.001 | < 0.001 | < 0.001 | 0.23 | 0.005 |
TNF-α (n = 69) | |||||||||
r | 0.162 | 0.302 | 0.169 | 0.236 | 0.495 | 0.437 | 0.450 | 0.024 | 0.360 |
p† | 0.18 | 0.012 | 0.17 | 0.05 | < 0.001 | < 0.001 | < 0.001 | 0.85 | 0.002 |
adj p‡ | 0.23 | 0.024 | 0.22 | 0.09 | < 0.001 | 0.001 | < 0.001 | 0.85 | 0.007 |
CCL2 (n = 69) | |||||||||
r | 0.170 | 0.449 | 0.362 | 0.297 | 0.210 | 0.230 | −1.02 | 0.047 | 0.170 |
p† | 0.16 | < 0.001 | 0.002 | 0.013 | 0.08 | 0.07 | 0.41 | 0.70 | 0.16 |
adj p‡ | 0.22 | 0.001 | 0.007 | 0.027 | 0.13 | 0.10 | 0.46 | 0.73 | 0.22 |
adj = adjusted; CCL2 = chemokine ligand 2; IDO = indoleamine 2,3-dioxygenase; IFN = interferon; IL = interleukin; KAT II = kynurenine aminotransferase II; KMO = kynurenine 3-monooxygenase; KYNA = kynurenic acid; QUIN = quinolinic acid; TDO = tryptophan-2,3-dioxygenase; TNF = tumour necrosis factor; TRP = tryptophan.
The n value includes both controls and depressed individuals.
Significance level for unadjusted values for multiple comparisons.
Adjusted for multiple comparisons using the Benjamini–Hochberg modification of the Bonferroni method.